While most of the tech world spent the first weeks of 2026 announcing layoffs, Boston’s WHOOP went in the opposite direction. On March 4, the Kenmore Square-based wearable health company announced it would add more than 600 new employees over the course of the year — a move that would increase its current workforce of roughly 800 people by as much as 75%. In a city that has grown accustomed to watching biotech dominate the headlines, a consumer health tech company quietly positioning itself for one of Boston’s most anticipated IPOs in years deserves a closer look.
The hiring push is not a defensive maneuver. The roles span software engineering, hardware development, research, design, product, and marketing — essentially every function across the company simultaneously. The majority of positions will be based at WHOOP’s Boston headquarters, with additional hiring planned across North America, Europe, the Gulf region, and Asia. Founder and CEO Will Ahmed framed the moment bluntly: “Right now, companies are debating whether to hire more people or just invest in AI. We are doing both.”
That kind of confidence reads differently when you look at the numbers behind it. WHOOP’s subscriptions have grown twenty times since 2020 and are up 75% over just the last two years. The company currently operates in 60 countries, with 60% of its revenue now coming from international markets — a notable shift from four years ago, when the U.S. accounted for roughly 70% of its member base. WHOOP has raised more than $400 million in venture capital to date, and its last financing round positioned it as the most valuable standalone wearables company in the world.
The product itself has evolved significantly from its origins as an athlete performance tracker. WHOOP’s latest medical-grade model includes an FDA-cleared ECG, atrial fibrillation detection, blood pressure insights, and a Healthspan feature that estimates a user’s biological age. The company is also rolling out blood biomarker analysis through its Advanced Labs platform, integrating a panel of health indicators that blur the line between consumer wellness device and clinical tool. It is a deliberate positioning — one designed to make WHOOP harder to dismiss as just another fitness gadget when the time comes to go public.
And that time appears to be approaching. A potential WHOOP IPO would be the first significant Boston tech company to go public since marketing software firm Klaviyo listed in 2023. Ahmed has said publicly that the company is well-positioned for a public offering over a horizon of roughly two years — a timeline that makes the current hiring surge read less like a growth bet and more like deliberate infrastructure-building ahead of a major transition.
WHOOP accepts approximately one in every 750 applicants, which means the 600 incoming hires will be drawn from a pool of nearly half a million candidates. That selectivity is part of the brand identity Ahmed has built — the idea that WHOOP, like the athletes who wear it, operates at a different standard. Whether that standard translates into a successful public market debut remains to be seen, but right now, Kenmore Square’s most interesting company is betting big on itself. Boston’s job market, at least, is better for it.
